Bacterial Molecule Can Slow Sjögren’s Progression, Preclinical Study Suggests

Bacterial Molecule Can Slow Sjögren’s Progression, Preclinical Study Suggests

292325

Bacterial Molecule Can Slow Sjögren’s Progression, Preclinical Study Suggests

Oral treatment with a molecule produced by bacteria, called colonization factor antigen I, can reduce or halt the progression of Sjögren’s syndrome, a mouse study suggests. Researchers believe these findings provide the basis for future testing in patients with Sjögren’s. The study, “Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome,” was published in the journal Arthritis Research…

You must be logged in to read/download the full post.